Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018

INTRODUCTION: After treatment with naltrexone extended-release injectable suspension (XR-NTX), a µ-opioid receptor antagonist, opioid tolerance is reduced from pretreatment baseline. Patients may be vulnerable to opioid overdose if they attempt to override the blockade during treatment, at the end o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Priya, McKinnell, Kimberley, Marino, Rose, Vunnava, Prashanthi, Liles-Burden, Marie A., Desai, Avani, Wenten, Madé, Fratantonio, James, Akerman, Sarah C., Sullivan, Maria A., Bloomgren, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892734/
https://www.ncbi.nlm.nih.gov/pubmed/33258068
http://dx.doi.org/10.1007/s40264-020-01020-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892734/
https://www.ncbi.nlm.nih.gov/pubmed/33258068
http://dx.doi.org/10.1007/s40264-020-01020-4

Ejemplares similares